撤回:西诺巴昔尼通过胰腺星状细胞的TGFβ/Smads途径抑制胰腺癌细胞的发展

4区 医学 Q2 Medicine
Evidence-based Complementary and Alternative Medicine Pub Date : 2023-12-13 eCollection Date: 2023-01-01 DOI:10.1155/2023/9843430
Evidence-Based Complementary And Alternative Medicine
{"title":"撤回:西诺巴昔尼通过胰腺星状细胞的TGFβ/Smads途径抑制胰腺癌细胞的发展","authors":"Evidence-Based Complementary And Alternative Medicine","doi":"10.1155/2023/9843430","DOIUrl":null,"url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2022/3719857.].</p>","PeriodicalId":12236,"journal":{"name":"Evidence-based Complementary and Alternative Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10733002/pdf/","citationCount":"0","resultStr":"{\"title\":\"Retracted: Cinobufacini Inhibits the Development of Pancreatic Cancer Cells through the TGF<i>β</i>/Smads Pathway of Pancreatic Stellate Cells.\",\"authors\":\"Evidence-Based Complementary And Alternative Medicine\",\"doi\":\"10.1155/2023/9843430\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>[This retracts the article DOI: 10.1155/2022/3719857.].</p>\",\"PeriodicalId\":12236,\"journal\":{\"name\":\"Evidence-based Complementary and Alternative Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10733002/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evidence-based Complementary and Alternative Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/2023/9843430\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence-based Complementary and Alternative Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2023/9843430","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

[本文撤回了文章 DOI:10.1155/2022/3719857.]。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Retracted: Cinobufacini Inhibits the Development of Pancreatic Cancer Cells through the TGFβ/Smads Pathway of Pancreatic Stellate Cells.

[This retracts the article DOI: 10.1155/2022/3719857.].

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Evidence-based Complementary and Alternative Medicine
Evidence-based Complementary and Alternative Medicine 医学-全科医学与补充医学
自引率
0.00%
发文量
1983
审稿时长
2.2 months
期刊介绍: Evidence-Based Complementary and Alternative Medicine (eCAM) is an international, peer-reviewed journal that seeks to understand the sources and to encourage rigorous research in this new, yet ancient world of complementary and alternative medicine. The journal seeks to apply scientific rigor to the study of complementary and alternative medicine (CAM) modalities, particularly traditional Asian healing systems. eCAM emphasizes health outcome, while documenting biological mechanisms of action. The journal is devoted to the advancement of science in the field of basic research, clinical studies, methodology or scientific theory in diverse areas of Biomedical Sciences. The journal does not consider articles on homeopathy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信